Novo Nordisk`s operating profit increased by 12% in Danish kroner and by 6% at constant exchange rates (CER) in the first six months of 2019
(WorldNews Denmark)

Financial report for the period 1 January 2019 to 30 June 2019 9 August 2019 Novo Nordisk`s operating profit increased by 12% in Danish kroner and by 6% at constant exchange rates (CER) in the first six months of 2019 Sales increased by 9% in Danish kroner and by 5% at CER to DKK 59.3 billion. Sales in International Operations increased by 13% in Danish kroner (12% at CER), driven by growth in all regions. Sales in North America Operations increased by 5% in Danish kroner (decreased by 2% at CER). Sales within Diabetes and obesity increased by 10% to DKK 50.1 billion (6% at CER), driven by Diabetes growing 4% at CER and Obesity growing 56% at CER. Sales within Biopharmaceuticals increased by...